Mechelen, Belgium-based Galapagos NV is extending its interest in fibrosis R&D with an early-stage collaboration with Evotec AG involving liver and other organ fibrosis, the second deal finalized by the former this year to target fibrotic diseases.
Under the latest fibrosis collaboration, announced Feb